On 10 November 2014, a research cooperation agreement was signed between Koç University and pharmaceutical company AstraZeneca, concerning research on drug development. Koç University Drug Research Center will be leading KU’s research effort.
AstraZeneca International Markets Vice President Mark Mallon and our president Prof. Dr. Umran İnan signed the agreement which provides KU researchers access to molecules included in the company’s Open Innovation Program. The scientific collaboration will be managed on the Koç University side by the Drug Research Center, led by Prof. Burak Erman.
Click here for the DHA news piece, and here is a video of the co-signing event.